Results 1 to 10 of about 301,535 (183)

Lack of general learning ability factor in a rat test battery measuring a wide spectrum of cognitive domains [PDF]

open access: yesJournal of Integrative Neuroscience, 2022
Objective: In the framework of a larger project aiming to test putative cognitive enhancer drugs in a system with improved translational validity, we established a rodent test battery, where different, clinically relevant cognitive domains were ...
Ferenc Kassai   +4 more
doaj   +1 more source

Role of Traditional Cardiovascular Risk Factors after Initiation of Statin Therapy: A PharmLines Inception Cohort Study

open access: yesCardiovascular Therapeutics, 2022
Background. Multiple studies and meta-analyses examined the role of traditional risk factors for cardiovascular events in statin treatment-naive patients.
Dennis Steenhuis   +3 more
doaj   +1 more source

Patient Perspectives on the Use of Digital Technology to Help Manage Cystic Fibrosis

open access: yesPulmonary Medicine, 2023
Background. Digital health technologies (DHTs) have shown potential to improve health outcomes through improved medication adherence in different disease states.
Alexandre H. Watanabe   +6 more
doaj   +1 more source

The Investigation of Combined Na+/Ca2+ Exchanger and the L-type Ca2+- Channel Inhibition in Langendorff-Perfused Isolated Guinea Pig Hearts [PDF]

open access: yesRomanian Journal of Cardiology, 2021
Objective: The sodium/calcium exchanger (NCX) and the L-type Ca2+-channel (LTCC) are nowadays considered the major transmembrane transport mechanisms that control Ca2+ homeostasis.
János PROROK   +3 more
doaj   +1 more source

Performance of the intracerebroventricularly injected streptozotocin Alzheimer’s disease model in a translationally relevant, aged and experienced rat population

open access: yesScientific Reports, 2022
The intracerebroventricularly (icv) injected streptozotocin (STZ) induced brain state is a widely used model of sporadic Alzheimer-disease (AD). However, data have been generated in young, naive albino rats.
Attila Gáspár   +6 more
doaj   +1 more source

SARS: pharmacotherapy [PDF]

open access: yesRespirology, 2003
The pharmacotherapy for severe acute respiratory syndrome (SARS) is controversial and largely anecdotal. Most patients with suspected SARS should initially be treated with potent antibiotics before proceeding to ‘anti‐SARS’ therapy. There is a spectrum of severity and rate of progression in SARS, and the stages of viral replication, inflammatory ...
Kenneth, Tsang, Nan Shan, Zhong
openaire   +2 more sources

Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy

open access: yesCancer Cell International, 2023
Background KRAS mutations are fraught with the progression of colorectal cancer and resistance to chemotherapy. There are pathways such as extracellular regulated protein kinase 1/2 (ERK1/2) and Akt downstream and farnesylation and geranylgeranylation ...
Masanobu Tsubaki   +9 more
doaj   +1 more source

Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians

open access: yesJournal of Pharmaceutical Policy and Practice, 2021
Background With the approval of biosimilars for subcutaneously administered products, such as adalimumab, etanercept and insulin, biosimilars become increasingly available in ambulatory care.
Liese Barbier   +5 more
doaj   +1 more source

Insomnia Pharmacotherapy [PDF]

open access: yesNeurotherapeutics, 2012
The benzodiazepine receptor agonists (BzRAs) a melatonin receptor agonist and a histamine antagonist have all been approved as hypnotics. Beyond their differing mechanisms of action, they have differences in pharmacokinetics, and among the BzRAs differences in receptor subtype affinity and formulations, which provides the physician with broad options ...
Timothy, Roehrs, Thomas, Roth
openaire   +2 more sources

Impact of type of anticoagulant on clinical outcomes in cancer patients who had atrial fibrillation

open access: yesScientific Reports, 2023
To date, evidence on optimal anticoagulant options in patients with AF who concurrently have active cancer remains elusive. To describe anticoagulant patterns and clinical outcomes among patients with a concomitant diagnosis of AF and cancer.
Chatree Chai-Adisaksopha   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy